• Home
  • News
  • Fortune 500
    • Fortune Global 500
    • Fortune 500 Europe
    • Fortune China 500
    • Fortune SEA 500
    • Great Place To Work
  • Tech
    • AI
    • Innovation
    • Cybersecurity
  • Finance
    • Personal Finance
    • Real Estate
    • Economy
    • Investing
    • Banking
    • Crypto
  • Leadership
    • Success
    • Future Of Work
    • Workplace Culture
    • C-Suite
    • CEO Initiative
  • Lifestyle
    • Arts & Entertainment
    • Travel & Leisure
    • Health
    • Well
    • Education
  • Rankings
    • Analytics
  • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Video
    • Podcasts
  • Home
  • News
  • Fortune 500
    • Fortune 500
    • Fortune Global 500
    • Fortune 500 Europe
    • Fortune China 500
    • Fortune SEA 500
    • Great Place To Work
  • Tech
    • Tech
    • AI
    • Innovation
    • Cybersecurity
  • Finance
    • Finance
    • Personal Finance
    • Real Estate
    • Economy
    • Investing
    • Banking
    • Crypto
  • Leadership
    • Leadership
    • Success
    • Future Of Work
    • Workplace Culture
    • C-Suite
    • CEO Initiative
  • Lifestyle
    • Lifestyle
    • Arts & Entertainment
    • Travel & Leisure
    • Health
    • Well
    • Education
  • Rankings
    • Rankings
    • Analytics
  • Multimedia
    • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Video
    • Podcasts
  • Asia
  • Europe
  • Analytics
  1. home
  1. home
  2. Celgene

Celgene

Page 2 of 2

FRANCE-ECONOMY-PHARMACEUTICALS-SANOFI
Health

Sanofi Just Went Hostile in Its Medivation Takeover Bid

By Sy Mukherjee
May 25, 2016
Drugs From European Pharmaceuticals Companies As Stocks Outperformed The Stoxx 600 Index By 1.2 percentage Points
Finance

Biotech Stocks Are Down 25% So Far This Year

By Sy Mukherjee
May 6, 2016
Scientists Just Made a Major Breakthrough in Personalized Cancer Treatment
Health

Scientists Just Made a Major Breakthrough in Personalized Cancer Treatment

By Sy Mukherjee
March 4, 2016
Inside Teva Pharmaceuticals Headquarters
Health

Celgene Settles U.S. Patent Litigation for Revlimid

By Reuters and Aaron Task
December 23, 2015
Key Speakers At The Stanford Institute For Economic Policy Research Forum
Leadership

Step aside Wall Street, small pharma CEO pay reaches for the sky

By Paul Hodgson
January 5, 2015

Most Popular

  • Innovation
    Ford CEO says a 'shocking' discovery after taking apart rival Tesla and Chinese EVs led to a 'brutal' business decision
    By Marco Quiroz-Gutierrez
  • Success
    Warren Buffett admits his Giving Pledge philanthropy was not ‘feasible’—he’s instead left his three kids $500 million a...
    By Preston Fore
  • Future of Work
    600 Paramount Skydance employees quit instead of returning to the office, and it cost the company $185 million, filings...
    By Sasha Rogelberg
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • MPW
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms of Use
  • Single Issues for Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work at Fortune
  • Diversity and Inclusion
  • Terms and Conditions
  • Site Map

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.